Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction

Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction

The article is devoted to issues of clinical diagnosis and treatment of patients with chronic cardiac failure and normal ejection fraction (CCF-NEF). Original clinical trials of felodipin efficacy designed to be maximally close to every-day clinical practice in Russia included hypertensive patients...

Full description

Bibliographic Details
Main Authors: Oksana Mikhaylovna Drapkina, Yaroslav Igorevich Ashikhmin, O M Drapkina, Ya I Ashikhmin
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2011-12-01
Series:Терапевтический архив
Subjects:
arterial hypertension
chronic cardiac failure
preserved ejection fraction
felodipin
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30935
id doaj-b3c7e753a6e9447995ba06f73ef546f3
record_format Article
spelling doaj-b3c7e753a6e9447995ba06f73ef546f32020-11-25T03:19:54Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422011-12-018312263427951Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fractionOksana Mikhaylovna DrapkinaYaroslav Igorevich AshikhminO M Drapkina0Ya I Ashikhmin1I. M. Sechenov First Moscow State Medical University, MoscowI. M. Sechenov First Moscow State Medical University, MoscowThe article is devoted to issues of clinical diagnosis and treatment of patients with chronic cardiac failure and normal ejection fraction (CCF-NEF). Original clinical trials of felodipin efficacy designed to be maximally close to every-day clinical practice in Russia included hypertensive patients with CCF-NEF. The results of these trials bring about the conclusion that felodipin not only maintain blood pressure at the target level but also improves diastolic function of the myocardium.https://ter-arkhiv.ru/0040-3660/article/view/30935arterial hypertensionchronic cardiac failurepreserved ejection fractionfelodipin
collection DOAJ
language Russian
format Article
sources DOAJ
author Oksana Mikhaylovna Drapkina
Yaroslav Igorevich Ashikhmin
O M Drapkina
Ya I Ashikhmin
spellingShingle Oksana Mikhaylovna Drapkina
Yaroslav Igorevich Ashikhmin
O M Drapkina
Ya I Ashikhmin
Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
Терапевтический архив
arterial hypertension
chronic cardiac failure
preserved ejection fraction
felodipin
author_facet Oksana Mikhaylovna Drapkina
Yaroslav Igorevich Ashikhmin
O M Drapkina
Ya I Ashikhmin
author_sort Oksana Mikhaylovna Drapkina
title Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
title_short Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
title_full Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
title_fullStr Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
title_full_unstemmed Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
title_sort calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2011-12-01
description The article is devoted to issues of clinical diagnosis and treatment of patients with chronic cardiac failure and normal ejection fraction (CCF-NEF). Original clinical trials of felodipin efficacy designed to be maximally close to every-day clinical practice in Russia included hypertensive patients with CCF-NEF. The results of these trials bring about the conclusion that felodipin not only maintain blood pressure at the target level but also improves diastolic function of the myocardium.
topic arterial hypertension
chronic cardiac failure
preserved ejection fraction
felodipin
url https://ter-arkhiv.ru/0040-3660/article/view/30935
work_keys_str_mv AT oksanamikhaylovnadrapkina calciumchannelsblockerfelodipinperspectivesinthetreatmentofarterialhypertensionandchroniccardiacfailurewithnormalejectionfraction
AT yaroslavigorevichashikhmin calciumchannelsblockerfelodipinperspectivesinthetreatmentofarterialhypertensionandchroniccardiacfailurewithnormalejectionfraction
AT omdrapkina calciumchannelsblockerfelodipinperspectivesinthetreatmentofarterialhypertensionandchroniccardiacfailurewithnormalejectionfraction
AT yaiashikhmin calciumchannelsblockerfelodipinperspectivesinthetreatmentofarterialhypertensionandchroniccardiacfailurewithnormalejectionfraction
_version_ 1724620311586930688

Similar Items